Analysis of maternal-offspring HLA compatibility, parent-of-origin effects, and noninherited maternal antigen effects for HLA-DRB1 in systemic lupus erythematosus
- PMID: 20191587
- PMCID: PMC2948464
- DOI: 10.1002/art.27426
Analysis of maternal-offspring HLA compatibility, parent-of-origin effects, and noninherited maternal antigen effects for HLA-DRB1 in systemic lupus erythematosus
Abstract
Objective: Genetic susceptibility to systemic lupus erythematosus (SLE) is well established, with the HLA class II DRB1 and DQB1 loci demonstrating the strongest association. However, HLA may also influence SLE through novel biologic mechanisms in addition to genetic transmission of risk alleles. Evidence for increased maternal-offspring HLA class II compatibility in SLE and differences in maternal versus paternal transmission rates (parent-of-origin effects) and nontransmission rates (noninherited maternal antigen [NIMA] effects) in other autoimmune diseases have been reported. Thus, we investigated maternal-offspring HLA compatibility, parent-of-origin effects, and NIMA effects at DRB1 in SLE.
Methods: The cohort comprised 707 SLE families and 188 independent healthy maternal-offspring pairs (total of 2,497 individuals). Family-based association tests were conducted to compare transmitted versus nontransmitted alleles (transmission disequilibrium test) and both maternally versus paternally transmitted (parent-of-origin) and nontransmitted alleles (using the chi-square test of heterogeneity). Analyses were stratified according to the sex of the offspring. Maternally affected offspring DRB1 compatibility in SLE families was compared with paternally affected offspring compatibility and with independent control maternal-offspring pairs (using Fisher's test) and was restricted to male and nulligravid female offspring with SLE.
Results: As expected, DRB1 was associated with SLE (P < 1 x 10(-4)). However, mothers of children with SLE had similar transmission and nontransmission frequencies for DRB1 alleles when compared with fathers, including those for the known SLE risk alleles HLA-DRB1*0301, *1501, and *0801. No association between maternal-offspring compatibility and SLE was observed.
Conclusion: Maternal-offspring HLA compatibility, parent-of-origin effects, and NIMA effects at DRB1 are unlikely to play a role in SLE.
Figures


Similar articles
-
Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.Diabetes Obes Metab. 2009 Feb;11 Suppl 1(Suppl 1):74-83. doi: 10.1111/j.1463-1326.2008.01006.x. Diabetes Obes Metab. 2009. PMID: 19143818 Free PMC article.
-
Maternal HLA class II compatibility in men with systemic lupus erythematosus.Arthritis Rheum. 2005 Sep;52(9):2768-73. doi: 10.1002/art.21256. Arthritis Rheum. 2005. PMID: 16142706 Free PMC article.
-
Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?Tissue Antigens. 1992 Sep;40(3):128-33. doi: 10.1111/j.1399-0039.1992.tb02104.x. Tissue Antigens. 1992. PMID: 1440567
-
Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.Int J Rheum Dis. 2015 Jan;18(1):17-28. doi: 10.1111/1756-185X.12528. Epub 2014 Dec 26. Int J Rheum Dis. 2015. PMID: 25546242 Review.
-
Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.J Autoimmun. 2011 Sep;37(2):104-12. doi: 10.1016/j.jaut.2011.05.004. Epub 2011 Jun 1. J Autoimmun. 2011. PMID: 21632208 Free PMC article. Review.
Cited by
-
Transmission disequilibrium analysis of whole genome data in childhood-onset systemic lupus erythematosus.Genes Immun. 2023 Aug;24(4):200-206. doi: 10.1038/s41435-023-00214-x. Epub 2023 Jul 24. Genes Immun. 2023. PMID: 37488248 Free PMC article.
-
A possible role for immunogenetic factors in myositis developing after vaccination in the pre-covid-19 era.Front Immunol. 2025 Aug 15;16:1539659. doi: 10.3389/fimmu.2025.1539659. eCollection 2025. Front Immunol. 2025. PMID: 40895572 Free PMC article.
-
Sex Hormones Determine Immune Response.Front Immunol. 2018 Aug 27;9:1931. doi: 10.3389/fimmu.2018.01931. eCollection 2018. Front Immunol. 2018. PMID: 30210492 Free PMC article. Review. No abstract available.
-
Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers.Genes Immun. 2020 Jan;21(1):27-36. doi: 10.1038/s41435-018-0055-7. Epub 2019 Jan 12. Genes Immun. 2020. PMID: 30635658 Free PMC article.
References
-
- Kaplan J, Land S. Influence of maternal-fetal histocompatibility and MHC zygosity on maternal microchimerism. J Immunol. 2005;174:7123–7128. - PubMed
-
- Hall JM, Lingenfelter P, Adams SL, Lasser D, Hansen JA, Bean MA. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood. 1995;86:2829–2832. - PubMed
-
- Claas FH, Gijbels Y, van der Velden-de Munck J, van Rood JJ. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science. 1988;241:1815–1817. - PubMed
-
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P20 RR020143/RR/NCRR NIH HHS/United States
- R01-AR-043274-14/AR/NIAMS NIH HHS/United States
- N01-AR-62277/AR/NIAMS NIH HHS/United States
- R01-AR-22804/AR/NIAMS NIH HHS/United States
- R01-AR-052300/AR/NIAMS NIH HHS/United States
- P01-AR-049084/AR/NIAMS NIH HHS/United States
- F31-AI-075609/AI/NIAID NIH HHS/United States
- R01 AR044804/AR/NIAMS NIH HHS/United States
- R01 AR052300/AR/NIAMS NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- K24 AR002175/AR/NIAMS NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- R01 AR043274/AR/NIAMS NIH HHS/United States
- P01-AI-083194/AI/NIAID NIH HHS/United States
- F31 AI075609/AI/NIAID NIH HHS/United States
- R01 AI063274/AI/NIAID NIH HHS/United States
- M01 RR000079/RR/NCRR NIH HHS/United States
- 5-M01-RR-00079/RR/NCRR NIH HHS/United States
- R01-AR-42460/AR/NIAMS NIH HHS/United States
- R37-AI-24717/AI/NIAID NIH HHS/United States
- P20-RR-020143/RR/NCRR NIH HHS/United States
- 5R01-A1-063274-06/PHS HHS/United States
- N01 AR062277/AR/NIAMS NIH HHS/United States
- K24-AR-02175/AR/NIAMS NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials